A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
Yufan JianMeina ZhaoJinyi CaoTingting FanWei BuYang YangWeiwei LiWei ZhangYi QiaoJingwen WangAidong WenPublished in: Drug design, development and therapy (2020)
These results suggest that GX1-modified NLCs enhanced the anti-tumor activity of PTX and reduced its toxicity effectively. GX1-PTX-NLCs may be considered as a potent drug delivery system for therapy of gastric cancer.